Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

vanutide cridificar

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
OBJECTIVES Long-term safety and tolerability of ACC-001 (vanutide cridificar), an antiamyloid- beta therapeutic vaccine, was… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Highly Cited
2016
Highly Cited
2016
Vanutide cridificar (ACC-001), an immunotherapeutic vaccine, is a potentially disease-modifying therapy that aims to reduce brain… Expand
2016
2016
BACKGROUND ACC-001 is an investigational therapeutic vaccine designed to elicit antibodies against the N-terminal peptide 1-7 of… Expand
2016
2016
BACKGROUND Vanutide Cridificar (ACC-001), a novel investigational immunotherapeutic vaccine designed to elicit antibodies against… Expand